Dessu Samuel, Mesele Molalegn, Habte Aklilu, Dawit Zinabu
Department of Public Health, College of Medicine and Health Sciences, Wolkite University, Wolkite, Southern Ethiopia, Ethiopia.
Department of Midwifery, College of Medicine and Health Sciences, Wolaita Soddo University, Wolaita, Southern Ethiopia, Ethiopia.
HIV AIDS (Auckl). 2021 Feb 17;13:205-215. doi: 10.2147/HIV.S296226. eCollection 2021.
According to the World Health Organization, more than seventeen million people were accessing ART in 2015 globally. Adherence to effective ART reduced the risk of transmitting the virus to uninfected persons. The government and other stakeholders' focus was high to reduce the rate of loss to follow-up in HIV programs among patients who are already on ART follow-up, but its incidence rate increases from time to time.
A retrospective cohort study was conducted among the records enrolled from 1 January 2013 to 30 December 2017 at Public hospitals in Southern Ethiopia. Data were entered into Epi info V 7 and exported to STATA V 14 for analysis. The Kaplan-Meier survival curve together with a log rank test was used to estimate the survival time of the ART attending patients. Variables which had p-value <0.05 in multivariable analysis using the cox proportional hazard model were declared as statistically significant.
The incidence rate of loss to follow-up from ART services among adults attending ART was 6.48 (95% CI:5.67,7.29) per 1000 person months. The cumulative survival probability at the end of the 10th, 20th, 40th and 60th follow-up month was 0.89 (95% CI:0.87,0.91), 0.82 (95% CI:0.79,0.85), 0.78 (95% CI:0.75,0.81) and 0.74 (95% CI:0.70,0.77), respectively. Distance >5 kilometers (AHR:3.71; 95% CI:2.32,5.95), not having registered phone number (AHR:2.52; 95% CI:1.76,3.60), not initiating Isoniazid (AHR:2.15; 95% CI:1.50,3.08), body mass index <18.50kg/m (AHR:1.87; 95% CI: 1.18; 2.97) and not having primary caregiver (AHR: 2.59; 95% CI: 1.84, 3.66) were statistically significant predictors of loss to follow-up.
The time until loss to follow-up was high in the first 20 months of the initiation of the ART and it declines after 20 months; longer distance between home and hospital, not having registered phone number, not initiating INH, lower body mass index and not having primary caregiver were the independent predictors of loss to follow-up from ART services.
根据世界卫生组织的数据,2015年全球有超过1700万人正在接受抗逆转录病毒治疗(ART)。坚持有效的抗逆转录病毒治疗可降低将病毒传播给未感染者的风险。政府和其他利益相关者高度重视降低已接受抗逆转录病毒治疗随访的患者在艾滋病项目中的失访率,但其发病率时有上升。
对2013年1月1日至2017年12月31日在埃塞俄比亚南部公立医院登记的记录进行回顾性队列研究。数据录入Epi info V 7并导出到STATA V 14进行分析。使用Kaplan-Meier生存曲线和对数秩检验来估计接受抗逆转录病毒治疗患者的生存时间。在使用cox比例风险模型的多变量分析中p值<0.05的变量被宣布具有统计学意义。
接受抗逆转录病毒治疗的成年人中,抗逆转录病毒治疗服务失访率为每1000人月6.48(95%置信区间:5.67,7.29)。在第10、20、40和60个随访月结束时的累积生存概率分别为0.89(95%置信区间:0.87,0.91)、0.82(95%置信区间:0.79,0.85)、0.78(95%置信区间:0.75,0.81)和0.74(95%置信区间:0.70,0.77)。距离>5公里(风险比:3.71;95%置信区间:2.32,5.95)、没有登记电话号码(风险比:2.52;95%置信区间:1.76,3.60)、未开始使用异烟肼(风险比:2.15;95%置信区间:1.50,3.08)、体重指数<18.50kg/m(风险比:1.87;95%置信区间:1.18;2.97)以及没有主要照顾者(风险比:2.59;95%置信区间:1.84,3.66)是失访的统计学显著预测因素。
在开始抗逆转录病毒治疗的前20个月内失访时间较高,20个月后下降;家与医院之间距离较远、没有登记电话号码、未开始使用异烟肼、体重指数较低以及没有主要照顾者是抗逆转录病毒治疗服务失访的独立预测因素。